MARKET

CLLS

CLLS

Cellectis
NASDAQ
2.830
-0.060
-2.08%
After Hours: 2.830 0 0.00% 16:04 06/26 EDT
OPEN
2.840
PREV CLOSE
2.890
HIGH
2.940
LOW
2.790
VOLUME
8.48K
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.350
MARKET CAP
204.72M
P/E (TTM)
-16.5594
1D
5D
1M
3M
1Y
5Y
1D
Cellectis amends 6-K to correct shareholder meeting voting results table
PUBT · 2d ago
Cellectis posts presentation for June 25, 2026 AGM
PUBT · 3d ago
Cellectis Shareholders Approve 2025 Accounts and Expand Capital-Raising Powers at June 25 Meeting
TipRanks · 3d ago
Cellectis Shareholders Approve Board-Backed Resolutions at June 25, 2026 Meeting
TipRanks · 3d ago
Cellectis held shareholder meeting; resolutions 1-29 adopted, 30 rejected
PUBT · 3d ago
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
Barchart · 3d ago
Weekly Report: what happened at CLLS last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at CLLS last week (0608-0612)?
Weekly Report · 06/15 09:38
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.